DIAAMOND Trial Long-Term Follow-Up approved

We’re pleased to announce the long-term follow-up phase has recently been added to the DIAAMOND Ava trial. The amendment extends the follow-up period by an additional five years to evaluate the long-term safety of Avatrombopag in aplastic anaemia participants previously enrolled in the trial.

For more information, please contact: sphpm.diaamond@monash.edu